Nemluvio (nemolizumab)

pCPA File Number: 23484

Negotiation Status:

Under consideration for negotiation

Indication(s):

Prurigo nodularis

Sponsor/Manufacturer:

Galderma Canada Inc.

CDA-AMC Project Number:

SR0861-000

pCPA Engagement Letter Issued:

Not Applicable

Negotiation Process Concluded:

Not Applicable